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Summary 
About a half of the antierythrocyte autoantibody transgenic (autoAb Tg) mice, in which almost 
aU B cells are detected in the spleen, lymph nodes, and Peyer's patches, but not in the peritoneal 
cavity, suffer from autoimmune hemolytic anemia. The occurrence of this disease is strongly 
linked to production of autoAb by activated peritoneal B-1 cells in the Tg mice. In this study, 
we have shown that oral administration  of lipopolysaccharides (LPS) activated B-1 cells in the 
lamina propria of the gut as well as the peritoneal cavity in the healthy Tg mice and induced 
the autoimmune symptoms in all the Tg mice. The activation of peritoneal and lamina propria 
B-1 cells by enteric LPS is found not only in the anti-RBC autoAb Tg mice and normal mice 
but also in the aly mice which congenitally lack lymph nodes and Peyer's patches. These results 
suggest that B-1 cells in the two locations may form a common pool independent of Peyer's 
patches and lymph nodes, and can be activated  by enteric thymus-independent antigens or polydonal 
activators such as LPS. The induction of autoimmune hemolytic anemia in the Tg mice by enteric 
LPS through the activation of B-1 cells in the lamina propria of gut and in the peritoneal cavity 
suggests that B-1 cells and bacterial infection may play a pathogenic role in the onset of autoimmune 
diseases. 
F 
unctional Ig genes are created by somatic DNA rearrange- 
ment of sub-exon DNA segments: V-D-J rearrangement 
for the heavy chain and V-J rearrangement for the light chain 
gene (1). Such a random genetic event on one hand contributes 
to the diversity of Ig repertoire, but on the other hand produces 
autoreactive B cells that recognize and potentially react with 
self-antigens. Studies on transgenic (Tg)* mice expressing Igs 
against self-antigens have dearly shown that autoreactive B 
cells are eliminated (clonal deletion) (2-4), and/or function- 
ally inactivated (clonal anergy) (4-6). Without such proper 
selection of autoreactive B cells (self-tolerance), these B cells 
would appear in vivo and produce autoantibodies (autoAbs), 
which are involved with the pathogenesis  of autoimmune 
diseases. Several lines of studies suggest that genetic and/or 
environmental factors such as nutrition and infection  may 
be involved in breakage of the self-tolerance and induction 
1 Abbreviations used in  this paper: autoAb, autoantibodies; GALT, gut- 
associated  lymphoid  tissues; HBS, Hank's  balanced  solution;  Tg, transgenic. 
of autoimmune diseases (7-9).  However, the precise mecha- 
nism of the occurrence of autoimmune diseases remains elu- 
sive due to their enormous complexity. 
A key to clarify the mechanism of autoimmune diseases 
lies in creating suitable animal models for defining the na- 
ture of the break-down of immunological tolerance. Previ- 
ously, we established and characterized a Tg mouse line car- 
rying the Ig genes derived from the anti-red blood cell (RBC) 
autoAb 4C8 (4). In these mice, almost all B cells are deleted 
in the periphery but a normal number of B-1 cells survived 
in the peritoneal  cavity, the sequested compartment from 
erythrocytes.  About 50%  of the animals of this transgenic 
line suffer from autoimmune hemolytic anemia. Production 
of the autoantibody by peritoneal  B-1 ceils was shown to 
be responsible for autoimmune hemolytic anemia in the Tg 
mice because apoptotic  death of the B-1 cells by exposure 
to RBCs completely cured autoimmune hemolytic anemia 
(10). It was puzzling why only a half of the Tg mice develop 
the autoimmune symptoms whereas the remaining half look 
completely healthy even though they have the same genetic 
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environmental factors  such as infection are suspected  to be 
involved in the the activation orB-1 cells and the subsequent 
onset of the autoimmune disease in the Tg mice, this possi- 
bility remains to be tested. 
B-1 cells consist of B-la cells with the Ly-1 (CD5) antigen 
and B-lb cells without the Ly-1 antigen. B-la and B-lb cells 
have the same characters  except  for expression  of the Ly-1 
antigen (11). B-1 cells are distinguished from conventional 
B cells by the anatomical localization, surface phenotypes, 
and functional characteristics  (12, 13). B-1 cells are virtually 
absent from lymph nodes and present at a low frequency in 
spleen; however, they constitute the major fraction of B cells 
in the peritoneal cavity. Several important questions have to 
be settled as to the origin, function, and development orB-1 
cells. Although adoptive transfer studies suggest that B-1 cells 
and conventional B cells have different developmental pathways 
through distinct progenitor cells  (14-17),  in vitro studies 
showed that B-1 cells may derive from conventional B cells 
(18). In addition, it remains to be tested whether B-1 cells 
are directly involved in the pathogenesis of autoimmune dis- 
eases (12, 13, 19). It is also unknown why the peritoneal cavity 
contains a large number of B-1  cells. 
Peritoneal B cells have been suggested to interact with gut- 
associated  lymphoid tissues  (GALT), composed of Peyer's 
patches,  mesenteric lymph nodes, lamina propria lympho- 
cytes and intraepithelial lymphocytes (20). B cells in GALT 
preferentially produce and transport IgA into the gut lumen 
(21).  Moreover, lymphocytes in GALT are known to have 
a unique homing pattern as follows: committed cells leave 
the Peyer's patches after antigenic stimulation, and migrate 
to mesenteric lymph nodes and via the thoracic duct into 
the blood circulation to the spleen; and finally many of these 
cells return to GALT (22).  However, the lineage and origin 
of B-1 and conventional B cells in GALT as well as the peri- 
toneal cavity remain to be clarified. 
In this study, we report that the oral administration of 
LPS induced the autoimmune disease in all the non-symp- 
tomatic autoAb Tg mice by activation of peritoneal B-1 cells. 
We have also shown that B-1 cells in the peritoneal cavity 
form a common pool with B-1 cells in lamina propria of the 
gut, independently from Peyer's patches and lymph nodes, 
serving as a part of the mucosal immune system for defending 
the invasion of  microorganisms via gut lumen. Taken together, 
it is likely that enteric bacterial antigens activate GALT and 
peritoneal B-1 cells, which eventually causes the autoimmune 
disease in the Tg mice. 
Materials and Methods 
Mice.  Homozygous Tg mice for the hea  W and light chain genes 
of the anti-RBC autoAb were established and maintained as de- 
scribed (4). By mating homozygous heavy and light chain Tg mice, 
we could get double Tg mice which carry both heavy and light 
chain transgenes of the auboAb. Normal littermates were also ob- 
tained in this procedure. Aly mice (23) were kindly given by Nippon 
Sinyaku Co., Ltd. (Kyoto, Japan). In this study mice were used 
at 8-12 wk after birth. 
LPS Administration.  LPS (Salmonella minnesota, [T4270] and 
Escherichia coli Serotype 026B6 [L8274a] Sigma Chemical Co., St. 
Louis, MO) was purchased and dissolved in PBS. In case of oral 
administration of LPS, 500 #1 of LPS solution was injected into 
the gut of mice through a polyethylene tube of 1 mm diameter. 
In case of  intramuscular and intraperitoneal administration of  LPS, 
500/~1 of LPS solution was injected into the back and abdominal 
regions of the mice, respectively, with a needle. 
Detection  for Ab-producing Cells.  The number oflgM-producing 
cells was measured by enzyme-linked immunospot (Elispot) assay 
as described previously (10) for detection of anti-RBC  autoAb 
producing cells except that plastic plates were coated with 100/~1 
of goat anti-mouse IgM Ab (Cappel Laboratories, Cochranville, 
PA) at the concentration of 10/zg/ml in PBS. 
Preparation of Cells from Each Compartment of GALT.  Under 
diethyl ether anesthesia, mice were sacrificed  and lymphoid cells 
from GALT  were isolated  according to the procedures reported pre- 
viously (24, 25). At first, after removing feces from the gut, all 
Peyer's patches and mesenteric  lymph nodes were separated  and lym- 
phoid cells were isolated by gentle rubbing with a steel mesh in 
Hank's balanced solution (HBS) supplemented  with 5% FCS. Next, 
the gut epithelium was stripped by treating the inverted gut seg- 
ments with HBS, followed  by shaking the gut for 15 min at 37~ 
in HBS containing 5 mM EDTA Na2 without Ca +2 and Mg +2. 
After two cycles of this procedure, the cells in the medium were 
collected for intraepithelial lymphocytes suspension. The gut seg- 
ments were digested by 0.015% collagenase  (Wako, Tokyo,  Japan) 
in PBS containing 2% FCS for 75 min at 37~  and cells suspen- 
sions were obtained for lamina propria lymphocytes. These two 
suspensions were passed through a glass wool column and the lym- 
phoid cells  were separated  from epithelial  ceUs with a Ficoll-isopaque 
gradient centrifugation (450 g, 30 min, 4~  to obtain the final, 
intraepithelial, and lamina propria lymphocytes, respectively. 
Flow Cytometry.  Single  cell suspensions of 106 mononuclear 
cells were pelleted and resuspended in  10/xl  of normal mouse 
serum for blocking the nonspecific binding of antibodies. After 
10 min incubation, one of first-reagent antibodies, i.e., rat anti- 
mouse B220 (RA3-6B2) mAb, mouse anti-Thy-1 (IgM class) mAb 
(ICN Biomedicals  Inc., Costa Mesa, CA), anti-Mac-1 mAb (M1/ 
70.15.115.5HL) or biotinylated-anti CD23Ab (gift of Dr. Yagita 
and Dr. Hirano, Juntendo University, Tokyo,  Japan) at the appro- 
priate dilution in PBS was added directly. After incubation, cells 
were washed  twice with I ml of  PBS containing  5% FCS and 0.05% 
sodium azide. Then phycoerythrin-conjugated anti-mouse  IgM 
antibody (Southern Biotechnology Associates, Birmingham, AL) 
or fluorescein-conjugated mouse anti-rat K mAb (Immunotech, 
Marseilles, France), was added as second-reagent antibody, in 10 
/~1 of PBS at appropriate concentrations, under the same condi- 
tions. After excluding dead cells by propion-iodine staining and 
gating the lymphoid cells in forward and scatter analysis, 104 viable 
lymphoid cells were analyzed on FACScan  |  (Becton Dickinson & 
Co., Mountain View, CA) and were plotted on quadruple loga- 
rithmic scales. 
Immunohistochemistry.  Identification  of  lymphocyte  surface 
markers was carried out by the avidin-biotin-peroxidase  complex 
technique (26). Under diethyl ether anesthesia, mice were killed 
by exsanguination, and Peyer's  patches and the small intestine were 
sliced and embedded with Tissue Tek. O.C.T. compound (Miles 
Inc., West Haven, CT) and frozen in liquid nitrogen. The frozen 
sections were cut by cryostat at 5/~m in thickness, and fixed in 
acetate for 10 min at 4~  Then these sections were immersed in 
0.228% periodic acid solution for 15 s at 30~  to block endoge- 
nous peroxidase activity (27). To block nonspeeific  binding between 
avidin and rectin-like substances on the specimen, slides were in- 
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tories, Inc., Burlingame, CA) for 60 min at room temperature. Fi- 
nally, all sections were rinsed three times in PBS and soaked in 
0.05M Tris-HC1 buffer, pH 7.6, peroxidase (0.015%), and 0.03% 
NiC12 as a substrate enhancer for 2-10 min. In control prepara- 
tions, primary antibodies were replaced by a biotin solution and 
avidin/biotin/peroxidase  complex  only without primary antibodies; 
control staining was all negative. 
Results 
Administration  of LPS Induces Autoimmune Disease in Anti- 
RBC AutoA b Tg Micg  In the previous study, we have demon- 
strated that ,o50%  of anti-RBC autoAb-Tg mice develop 
hemolytic anemia due to the autoAb production by perito- 
neal B-1 cells, whereas the remaining half are almost com- 
pletely healthy (4). This resuh suggests that environmental 
factors especially infection may be involved in the activation 
of peritoneal B-1 cells and the occurrence of the autoimmune 
disease. To test this possibility, we used LPS of S. minnesota, 
which may mimic bacterial infection by serving as polyclonal 
activator of B cells. We administered LPS orally, intramuscu- 
larly, or intraperitoneally into nonanemic Tg mice, whose 
hematocrit values were >40%.  Regardless of the routes of 
LPS administration, anemia was induced in all the Tg mice 
that received  LPS (Fig.  1).  In case of intramuscular or in- 
traperitoneal injections of LPS, lower doses of LPS (<100 
#g/mouse) could induce hemolytic anemia in the Tg mice 
but higher doses of LPS (>100 #g/mouse) were lethal, prob- 
ably because of the hemorrhagic necrosis (28). On the other 
hand, oral administration of LPS induced hemolytic anemia 
in a dose-dependent manner up to 200 #g/mouse in the non- 
anemic Tg mice. The different dose effects of LPS between 
oral administration and systemic injection may depend, at 
least in part,  on different absorption rates  of LPS. 
Activation of B-I Cells Is Responsible for Autoimmune Symp- 
toms in LPS-treated Tg Mice.  To see whether the activation 
of peritoneal B-1 cells is involved in the LPS-induced autoim- 
mune disease shown in the naturally occurring autoimmune 
hemolytic anemia, we measured the number of anti-RBC 
Ab producing cells in the spleen, bone marrow, and perito- 
neal cavity of the LPS-treated Tg mice. Unexpectedly, only 
oral administration of LPS increased  dose dependently the 
number of Ab-producing cells in the peritoneal cavity whereas 
intraperitoneal or intramuscular injection of LPS did not ac- 
tivate peritoneal B cells (Fig. 2). On the other hand, B cells 
in the spleen  and bone marrow were activated by systemic 
administration of LPS but did not respond to oral adminis- 
tration of LPS. The same results were obtained when we used 
LPS of E.  coli (data not shown). 
To clarify the character of B cells activated by LPS, we ex- 
amined B cells in the spleen and peritoneal cavity of the Tg 
mice by flow cytometry. After intramuscular or oral injec- 
tion of LPS, the majority of B cells (B220 + , IgM +) in the 
spleen  were  CD23-  (Fig.  3).  Peritoneal B  cells  after in- 
tramuscular or oral administration of LPS were also almost 
all Mac-1 + and CD23-.  These results suggest but do not 
demonstrate that LPS-activated  B cells in the Tg mice may 
be B-1 cells but not conventional B cells. As spleen B-1 cells 
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Figure  1.  Injection  of LPS ag- 
gravates hemolytic anemia dose- 
dependently. Salmonella LPS, sus- 
pended in PBS, was administered 
orally (~a), intramuscularly  (i.m.), 
or intraperitoneally  (i.p.) to non- 
anemic  Tg mice. Hematocrit  value 
of  the peripheral blood  from  each 
mouse  was measured  at days  0, 3, 
and 7. The bars indicate  the stan- 
dard deviation  of the values  of the 
three to five mice. Amounts of 
LPS used  per mouse  are; O, 0 #g; 
O, 10 #g; [~, 100 #g; A, 200 #g. 
are indistinguishable from activated conventional B cells by 
the surface phenotype, an undetectable number of residual 
conventional B cells might have proliferated in response to 
LPS stimulation in spleen.  It is safe to conclude, however, 
that activated B cells in both the spleen and the peritoneal 
cavity after LPS injection have the same surface phenotypes 
as B cells in the nontreated Tg mice. 
To confirm the pathogenic role of B-1 cells in induction 
of the  autoimmune  disease  in  LPS-stimulated anti-RBC 
autoAb-Tg mice, we established  male F-1 mice by crossing 
anti-RBC autoAb-Tg mice with CBA/N mice which bear 
the X-linked immunodeficiency (xid) mutation. Mice with 
the x/d mutation lack B-1 cells (29) and show profound defects 
in producing the antibody in response to immunization with 
thymus-independent type-2 antigens such as protein-free LPS 
and hapten-polysaccharide conjugates. However, the response 
to protein antigens and thymus-independent type-1 antigens 
p.o.  i.m.  Lp. 
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Figure 2.  Peritoneal  B cells are activated  by oral  administration  of LPS, 
but not by intramuscular or intraperitoneal  injection of LPS. 7 d after 
oral, intramuscular,  or intraperitoneal  injection  of Salmonella LPS to the 
nonanemic transgenic mice, the number of IgM producing cells in 10  5 
cells of spleen, bone marrow (BM) or peritoneal cavity  (PEC) was mea- 
sured  by Elispot as described  in experimental  procedures.  Each experiment 
was carried out in three  Tg mice  and the bars show  the standard  deviation. 
113  Murakami  et al. SPL 
i~ 
__i  .3  I 0.6  0.1 
!!i. 
--B220---~  --C  D23---~ 
PEC 
~i~  -~ 
--Mac 1  ~  --CD23-m~  ,,.- 
Figure 3.  LPS-activated  B cells  in Tg mice  are mostly  B-1 cells. Salmonella 
LPS (100/xg/mouse),  was administ~d to Tg mice  intramuscularly  or orally. 
After 7 d, spleen  and peritoneal  cells were stained with antibodies specific 
to B220, IgM, CD23 and analyzed  with FACScan  |  (Becton  Dickinson 
& Co.). The number in each figure shows the percentage of B cells 
(B220 §  , IgM +) or B-1 cells (Mac-1  +  , IgM +, IgM +  , CD23-). 
such as lipoprotein-containing LPS is normal (30). Indeed, 
in anti-RBC autoAb-Tg/xid mice, neither B-1 nor conven- 
tional B cells existed in the peritoneal cavity and the spleen 
(Fig. 4). As the controls the Tg mice contained only B-1 cells 
(B220  l~  IgMhig  h,  CD23-)  in the peritoneal cavity, while 
CBA/N mice contained only conventional B cells (B220 +, 
IgM +,  CD23 +) in the spleen and peritoneal cavity. In ad- 
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Figure 4.  Few B cells exist in the peritoneum as well as in the spleen 
in Tg/xid  mice. Spleen  or peritoneal  lymphocytes  were  collected  from  Tg/x/d, 
Tg, and CBA/N mice, stained with antibodies against B220, IgM, and 
CD23, and analyzed  with FACScan  |  Numbers indicate the percentage 
of B cells or B-1 cells. 
Table  1.  Occurrence  of Hemo~tic Anem~ by LPS Adminbtmtion 
Tg/xid  Tg  CBA/N 
i.m.  0/3  3/3  0/3 
p.o,  0/3  3/3  0/3 
100 #g LPS in PBS were injected orally (p.o.) or intramuscularly (i.m.) 
into three each of Tg/xid,  Tg, and CBA/N male mice. At day 7, the 
occurrence  of hemolytic  anemia was examined  by measuring the hematocrit 
value of the peripheral blood from each mouse. Mice with a hematocrit 
value <40% were diagnosed as hemolytic  anemia. LPS (E. coli Serotype 
026B6, catalog no. L8274a; Sigma Chemical Co.) used in this study con- 
tains 5-10% protein, and activated B cells in CBA/N mice (data not 
shown). 
dition, neither oral nor intramuscular administration of lipo- 
protein-containing LPS could induce hemolytic anemia in the 
Tg/xid F1 male mice whereas the control autoAb Tg mice 
responded to LPS as described above (Table 1). Since the ab- 
sence orB-1 cells eliminates autoimmune symptoms induced 
by either oral or intramuscular administration of LPS in the 
Tg/xid mice, B-1 cells must be responsible for production 
of autoAbs upon LPS administration. These results suggest 
that enteric LPS may activate B-1 cells in the peritoneal cavity, 
and systemically administered LPS may activate B-1 cells in 
the spleen and bone marrow. 
Lamina Propria also Contains B-I Cells That Escape  from Clonal 
Deletion.  To assess how enteric LPS activates peritoneal B-1 
cells in the Tg mice, we examined B cells in each compart- 
ment of GALT of the Tg mice. Visual examination showed 
that anti-RBC autoAb-Tg mice have the normal number and 
normal size of Peyer's patches and mesenteric lymph nodes 
(data not shown). Immunohistochemical staining of the gut 
tissues  showed that a normal number of IgM + cells were 
found in the lamina propria of the gut (Fig. 5). These IgM + 
cells in the lamina propria of the Tg mice were also stained 
with the $54 Ab which recognizes the idiotype of the anti- 
RBC Ab (4C8) (data not shown). Although a normal number 
of T  cells was found, only a small  number of IgM + cells 
were present in Peyer's patches. These results indicate that 
autoreactive B cells in the lamina propria of the gut escape 
from clonal deletion like peritoneal B cells whereas autoreac- 
tive B cells in the Peyer's patches are deleted like spleen B cells. 
To characterize IgM § cells of the lamina propria of the 
gut, we analyzed mononuclear cells from epithelia, lamina 
propria, Peyer's patches,  and mesenteric lymph nodes by flow 
cytometry. In the Tg mice, B cells (IgM +, B220 +) were al- 
most completely deleted in the Peyer's patches and mesen- 
teric lymph nodes as is  the case for the spleen and lymph 
nodes (Fig. 6). However, the lamina propria contained a normal 
number of B cells (IgM +,  B220 +) in agreement with im- 
munohistochemical analysis.  More than 90%  of B cells in 
the lamina propria of the  gut  were Mac-1 +  (Fig.  6)  and 
$54 +  (data  not  shown),  indicating  that lamina propria B 
cells are almost all autoreactive B-1 cells.  In normal mice, 
B cells in Peyer's patches and mesenteric lymph nodes are al- 
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in the lamina propria as well as the peritoneal cavity are B-1 
cells. Intraepithelial lymphocytes  of  both Tg and normal mice 
were almost all T cells, and B cells were hardly detected (data 
not shown), as reported previously (31, 32).  In summary, 
autoreactive B-1 cells survive from donal deletion in the lamina 
propria and the peritoneal cavity of the Tg mice. By con- 
trast, almost all the B cells are deleted in Peyer's patches, lymph 
nodes and spleen of anti-RBC autoAb Tg mice. These results 
strongly suggest that lamina propria B-1 cells may be gener- 
ated independently of Peyer's patches and may have a close 
relationship with peritoneal B-1 cells. 
Oral Administration of  LPS Appears to Activate B-I Cells First 
in the Lamina Proloria  and then in the Peritoneal Cavity.  To assess 
whether peritoneal B-1  cells are functionally related with 
lamina propria B-1 cells, we measured the number of IgM- 
producing cells in each compartment of GALT before and 
after oral administration of LPS to the Tg and normal mice. 
In the Tg mice that contain the normal number of B-1 cells 
and few conventional B cells in the peritoneal cavity and GALT, 
oral administration of LPS increased  the number of IgM- 
producing cells 8-fold in the lamina propria and 11-fold in 
the peritoneal cavity whereas IgM-producing ceils were not 
detected in Peyer's patches either before or after administra- 
tion of LPS (Table 2). Similarly in normal mice, the activa- 
tion of peritoneal and lamina propria B cells was induced only 
by the oral administration of LPS but not by intraperitoneal 
or intramuscular injection of LPS, whereas B cells in Peyer's 
patches were activated by administration of LPS through any 
routes. The results again support the above conclusion that 
the peritoneal and lamina propria B-1 ceUs are related and 
independent from Peyer's patch B cells. Judging from the ana- 
tomical position of peritoneal cavity and lamina propria of 
the gut, enteric LPS may first activate lamina propria B-1 
cells and then peritoneal B-1 cells, leading to the induction 
of the autoimmune disease in anti-RBC autoAb Tg mice. 
To confirm that activation of B-1 cells in the lamina propria 
and peritoneal cavity does not depend on Peyer's patch B cells, 
we administered LPS orally to the mice with the aly muta- 
tion, which causes loss of lymph nodes and Peyer's patches 
(23). 7 d after oral administration of LPS, the number of IgM- 
producing cells in the peritoneal cavity and the lamina propria 
increased by eight- to ninefold in aly/aly mice (Table 2). The 
level of stimulation in aly/aly mice was not significally different 
from that in aly/+  mice, which contain normal numbers of 
Peyer's patches.  These results clearly demonstrate that peri- 
toneal and lamina propria B cells can be activated by enteric 
antigens in the absence  of Peyer's patches. 
Discussion 
LPS Activates B-1 Cells and Induces the Autoimmune Disease 
in the Tg Mice.  In this study we have shown that LPS ad- 
ministration  through  either muscle, peritoneal cavity,  or 
mouth induces hemolytic anemia in the Tg mice (Fig.  1), 
which depends on the presence  and activation of B-1 cells 
because the Tg/xid male mice did not become anemic by LPS 
injection (Fig.  4, Table 1). Intramuscular or intraperitoneal 
administration of LPS appears to activate a small number of 
B-1 ceils present in the spleen but not B-1 cells in the perito- 
Table  2.  Increased  Number of tgM~producing Cells in GAL T  by LPS Injection 
No. of IgM-producing cells 
Routes  of LPS 
Mice  administration  PEC  LPL  P.P. 
per I0  s cells 
Tg  none  28  -+  6  23  +_  12 
p.o.  312  +-  72  179  +_  30 
Normal  none  122  +  16  48  _+  6 
i.m.  136  +_  32  62  +_  8 
i.p.  98  -+  26  58  _+  12 
p.o.  336  _+  32  132  _+  26 
aly/+  none  92  _+  13  42  _+  14 
p.o.  521  -+  89  340  _+  21 
aly/aly  none  48  +-  18  32  _+  16 
p.o.  336  -+  28  282  _+  48 
<~5 
<~5 
52  _+  12 
262  +-  24 
302  +  31 
282  -+  48 
The numbers of IgM producing  cells  in the peritoneal  cavity,  lamina  propria, and Peyer's patch were examined  hefore  and 7 d after  oral administration 
of 100/~g of LPS to normal mice (C57/BL6), Tg mice, and mice with heterozygous  (aly/+ ) or homozygous  aly mutation (aly/aty). aly/+  mice 
have almost normal phenotype  but aly/aly mice lack Peyer's patches and lymph nodes congenitally  (23). Each experiment was done in three mice. 
Each number indicates mean +_  S.D. PEC, peritoneal exuded cells; LPL, lamina propria lymphocytes;  P.P., Peyer's patch. 
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ministration of LPS activates peritoneal  B-1 cells preferen- 
tially. Since the activation of peritoneal B-1 cells  is responsible 
for spontaneous autoimmune hemolytic anemia that occurs 
in a half of  the Tg mice (10), oral administration of  LPS mimics 
the physiological onset of the autoimmune disease  in the anti- 
RBC autoAb-Tg mice. The anti-RBC autoAb-Tg mouse thus 
provides a unique autoimmune model system in which we 
can induce the disease without an exception by oral adminis- 
tration of  LPS (Fig. 1) and cure the disease without an excep- 
tion by intraperitoneal injection of the self-antigen RBC (10). 
Enteric Bacterial Infection May Be Involved in the Occurrence 
of the Autoimmune Disease in the Tg Mice.  The fact that en- 
teric LPS can induce the symptoms similar to spontaneously 
occurring autoimmune hemolytic anemia in the Tg mice sug- 
gests that infection of  bacteria through the gut may  be respon- 
sible for triggering the autoimmune disease that occurs spon- 
taneously in a half of the Tg mice. Indeed, the incidence of 
the autoimmune hemolytic anemia sharply decreased when 
we moved the Tg animal colony into cleaner facilities (data 
not shown). Several  lines of evidence indicate that bacterial 
infection may activate autoreactive lymphocytes in vivo by 
117  Murakami  et al. Figure  S.  Histochemical  analysis of GALT in 
Tg mice. Axial  sections  of the gut in the Tg mice 
(A and C) and normal  littermates  (B and D) were 
stained with biotin-labeled  polyclonal  anti-mouse 
IgM Ab by the avidin/biotin/peroxidase  complex 
technique (26). Arrows  indicate  lamina  propria B 
cells. Magnification:  40x in Peyer's  patches  (A and 
B) and 100 x  in lamina propria lymphocytes  (C 
and D). 
several mechanisms. LPS derived from gram-negative bacteria 
is well known to activate B cells polyclonally and the ad- 
ministration of LPS induces the production of autoantibodies 
even in normal mice (33).  Enterotoxins derived from bac- 
teria can bind MHC nonspecifically on B cells and a specific 
T cell receptor on T cells, stimulate and expand a wide popu- 
lation ofT cells as superantigens (34). Autoreactive lympho- 
cytes may be activated by the infection of  bacteria and viruses, 
which have certain structural similarities with self-antigens 
(molecular mimicry) (35). 
The induction of autoimmune disease by infection was sug- 
gested recently in  experimental  allergic  encephalomyelitis 
(EAE) Tg model mice, in which all T  cells express a myelin 
basic protein-specific T cell receptors.  EAE did not occur in 
specific pathogen-free conditions, but the frequency of au- 
toimmune symptom increased in conventional conditions (36). 
However, there exist several arguments against the associa- 
tion of autoimmune disease with infection; the frequency of 
autoimmune disease is known to increase in nonobese insulin- 
dependent diabetus mice breeding in specific pathogen-free 
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Figure 6.  Flow  cytometric  analysis  of GALT of Tg and normal  mice. 
Lymphocytes  were  collected  from  intraepithelia  (IEL),  lamina  propria (LPL), 
Peyer's patches (P.P.), and mesenteric  lymph nodes (MLN) of the small 
intestine  of the Tg mice  or normal  littermates,  and stained  with antibodies 
against Thy-1, IgM, and B220 or antibodies against IgM and Mac-1. 
Numbers indicate the percentage  of B cells (IgM  +, B220  +) or B-1 (Mac- 
1  +, IgM+). 
conditions (37) or to remain unchanged in autoimmune gas- 
tritis breeding in germ-free conditions (38).  In this study, 
we showed that LPS induced autoimmune disease in anti- 
RBC autoAb Tg mice, but other mechanisms or molecules 
associated with bacterial infection may be involved in the oc- 
currence of autoimmune diseases. It also remains to be tested 
whether the activation of autoreactive B-1 cells by intestinal 
bacteria is involved in the occurrence of other autoimmune 
diseases in humans and mice. 
Enteric LPS May Activate Lamina Propria B-1 Cells before 
Peritoneal B-1 Cells. It is an intriguing question how enteric 
LPS activates peritoneal B-1 cells. We suspected communica- 
tion between the peritoneal and GALT lymphocytes. Flow 
cytometric and histochemical analysis of GALT of the Tg mice 
demonstrated that only B-1 cells existed in the peritoneum 
and the lamina propria whereas conventional B cells were 
almost completely deleted from Peyer's patches and mesen- 
teric lymph nodes (Fig. 6) as was the case for spleen B cells. 
Moreover, both peritoneal and lamina propria B-1 cells were 
effectively activated by oral administration of LPS but not 
by systemic injection of LPS (Fig.  2, Table 2). These results 
suggest a scenario that lamina propria B-1 cells are first acti- 
vated by enteric LPS,  and move into the peritoneal cavity. 
Such linkage of B cells in the peritoneal cavity and GALT 
is not unique to the Tg mice as B cells in the peritoneal cavity, 
lamina propria, and Peyer's patches of normal mice were all 
activated by enteric LPS  (Table 2).  The traffic of B-1  cells 
from the peritoneal cavity to the lamina propria have already 
been shown by the experiment that peritoneal B cells from 
host mice differentiated into Ab-producing cells in the lamina 
propria of irradiated recipient mice (20). Frequent migration 
may take place between peritoneal and lamina propria B-1 cells. 
GALT Is Composed of Two Different Lineages of Lympho- 
cytes.  Peyer's patches are believed to be necessary for the ac- 
tivation of B cells in GALT. M  cells,  which are located in 
the luminal side of Peyer's patches, uptake enteric antigens 
and transport them into Peyer's patches. After stimulation 
with antigens in Peyer's patches, B ceils circulate into the pe- 
riphery and return to GALT (22).  However, so far it is not 
clear whether B-1 cells are involved in this circulation of B 
cells in GALT. In this study, we have demonstrated that, in 
normal mice, Peyer's patches contain few B-1 cells and abun- 
dant conventional B cells whereas B-1 cells preferentially exist 
in the lamina propria of the gut as well as in the peritoneal 
cavity (Fig.  6).  In addition, in anti-RBC autoAb Tg mice, 
B-1 cells existed in the lamina propria and in the peritoneal 
cavity in spite of almost total absence of conventional B cells 
in every lymphoid organs including GALT. These B-1 cells 
in the two locations were activated by enteric bacterial an- 
tigens such as LPS. We have also demonstrated that both peri- 
toneal and lamina propria B-1 cells are activated by oral ad- 
ministration of LPS even in aly mice, which lack Peyer's patches 
(Table 2). These results clearly demonstrate that conventional 
B cells in Peyer's patches are separate from and not linked 
with peritoneal and lamina propria B-1 cells, and that GALT 
contains two separate lineages of B cells; one is conventional 
B cells whose generation is probably dependent on Peyer's 
patches; the other is lamina propria B-1 cells which commu- 
nicate with B-1 cells in the peritoneal cavity and grow in- 
dependently of Peyer's patches. 
Intraepithelial T  cells, frequently reactive to enteric bac- 
teria with strong killer activities,  partly originate indepen- 
dently of the thymus and partly have 3//8 T  cell receptors 
(31, 32). B-1 cells and 7/8 T cells share many common char- 
acteristics; predominant localization outside lymphoid tissues 
such as the gut and restricted antigen specificity to enteric 
and self-antigens. These primitive immune systems must have 
played an important role for the first line of defense against 
invading pathogens in lower vertebrate until more sophisti- 
cated immune systems, i.e., conventional B cells and ee/fl T 
cells, arose later in evolution. Upon the invasion of bacteria, 
antibacterial IgM antibodies, albeit with low affinity, may 
be immediately produced by B-1 cells in the peritoneal cavity 
and the lamina propria.  Subsequently, after somatic muta- 
tion and class switching of conventional B cells in Peyer's 
patches, IgG or IgA class antibodies with high affinity will 
be produced. Since the gut mucosa is continuously attacked 
by numerous microorganisms, GALT may require two layered 
defense lines,  namely the ancestral immune system of 3//8 
T and B-1 cells, and the modern immune system of oe/3 T 
and conventional B cells. 
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